Highlights of Vitreoretina

Register      Login

VOLUME 17 , ISSUE 2 ( Junio, 2024 ) > List of Articles

Diferenciación Clínica a través de los Cambios Vasculares Retinianos entre Enfermedad Plus y Enfermedades Cardiacas Congénitas

Benjamín Aboytes Ríos, Ramsés Rosales Díaz, Kitty Carolina Franco Ramírez, Jans Fromow Guerra, Paulina Ramírez Neria, María Ana Martínez Castellanos

Keywords : Enfermedad plus, retinopatía del prematuro, premaurez, enfermedad cardiaca congénita

Citation Information : Ríos BA, Díaz RR, Ramírez KC, Guerra JF, Neria PR, Castellanos MA. Diferenciación Clínica a través de los Cambios Vasculares Retinianos entre Enfermedad Plus y Enfermedades Cardiacas Congénitas. 2024; 17 (2):4-9.

DOI: 10.5005/hov-10102-17201

Published Online: 25-06-2024

Copyright Statement:  Copyright © 2024; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Objetivo: Reportar las diferencias en los cambios vasculares retinianos entre enfermedad plus y cambios vasculares retinianos secundarios a enfermedades cardiacas congénitas. Métodos: Se revisaron 30 casos clínicos, estudios y revisiones en los cuales se reportaban cambios vasculares retinianos en enfermedades cardiacas congénitas. Conclusiones: La enfermedad Plus y las cardiopatías congénitas pueden presentar tortuosidad vascular, especialmente la cardiopatía congénita cianótica (CC), pero la principal diferencia es que el diámetro de dilatación venular se presenta significativamente aumentado en la enfermedad de Retinopatía del Prematuro (ROP, por sus siglas en inglés) plus. Distinguir entre enfermedad plus y cambios vasculares por CC es crucial para el tratamiento adecuado, ya que estas condiciones requieren manejos diferentes. La investigación adicional en este campo es necesaria para mejorar la precisión diagnóstica y terapéutica en estas patologías.


PDF Share
  1. Vilela, M. A. P., Amaral, C. E. V., & Ferreira, M. A. T. (2021). Retinal vascular tortuosity: Mechanisms and measurements. European Journal of Ophthalmology, 31(3), 1497–1506.
  2. McLeod DS, Hasegawa T. The initial fetal human retinal vasculature develops by vasculogenesis. Dev Dyn. 2006;235:3336-3347.
  3. Harrel SN, Brandon DH. Retinopathy of prematurity: the disease process, classifications, screening, treatment and outcomes. Neonatal Netw. 2007;26:371-378.
  4. Mintz-Hittner H. Retinal devolpment and the pathopysiology of retinopathy of prematurity. IN: Polin RA, Fow WW, Abman SH, eds. Fetal and neonatal physiology. Philadelphia. Saunder; 2011. p. 1875-1881.
  5. Romo-Aguas JC, González-Hleón A, Meraz-Gutiérrez MP, et al. Retinopathy of prematurity: Incidence report of outliers based on international screening guidelines. Int J Retin Vitr. 2019;5:1-6.
  6. Dogra MR, Katoch D, Dogra M. An Update on Retinopathy of Prematurity (ROP). Indian J Pediatr. 2017;84:930-936.
  7. Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implications for screening programs. Pediatrics. 2005;115.
  8. Fettah N, Kabatas EU, Dogan V, et al. Retinovascular findings in newborns with critical congenital heart disease: A case series. Arch Argent Pediatr. 2017;115:e175-e178.
  9. Johns KJ, Johns JA, Feman SS. Retinal Vascular Abnormalities in Patients with Coarctation of the Aorta. Arch Ophthalmol. 1991;109:1266-1268.
  10. Chiang, M. F., Quinn, G. E., Fielder, A. R., Ostmo, S. R., Paul Chan, R. v., Berrocal, A., Binenbaum, G., Blair, M., Peter Campbell, J., Capone, A., Chen, Y., Dai, S., Ells, A., Fleck, B. W., Good, W. v., Elizabeth Hartnett, M., Holmstrom, G., Kusaka, S., Kychenthal, A., … Zin, A. (2021). International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology, 128(10), e51–e68.
  11. Chiang, M. F., Gelman, R., Williams, S. L., Lee, J. Y., Casper, D. S., Martinez-Perez, M. E., & Flynn, J. T. (2008). Plus disease in retinopathy of prematurity: Development of composite images by quantification of expert opinion. Investigative Ophthalmology and Visual Science, 49(9), 4064–4070.
  12. Good WV, Hardy RJ. The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP). Ophthalmology 2001; 108.
  13. Zeng G, Taylor SM, McColm JR, et al. Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood. 2007;109:1345-1352.
  14. Geisen P, Peterson LJ, Martiniuk D, et al. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis. 2008;14:345-357.
  15. Fettah N, Kabatas EU, Dogan V, et al. Retinovascular findings in newborns with critical congenital heart disease: A case series. Arch Argent Pediatr. 2017;115:e175-e178.
  16. Wong TY and McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 2005; 73–74: 57–70.
  17. Nasir-Ahmad, S., Cordina, R., Liew, G., McCluskey, P., & Celermajer, D. (2018). The eye in CHD. Cardiology in the Young, 28(8), 981–985.
  18. Johns KJ, Johns JA, Feman SS. Retinal Vascular Abnormalities in Patients with Coarctation of the Aorta. Arch Ophthalmol. 1991;109:1266-1268.
  19. Singh RB, Saini C, Shergill S, et al. Window to the circulatory system: Ocular manifestations of cardiovascular diseases. Eur J Ophthalmol. 2020;30:1207-1219.
  20. Mansour AM, Bitar FF, Traboulsi EI, et al. Ocular pathology in congenital heart disease. Eye. 2005;19:29-34.
  21. Cordina R, Leaney J, Golzan M, et al. Ophthalmological consequences of cyanotic congenital heart disease: Vascular parameters and nerve fiber layer. Clin Exp Ophthalmol. 2015;43:115-123.
  22. Stepanov VS, Ovsyannikov AV, Tatyan- chenko VK. Angioarchitectonics of the canine eye ball vessels, normal and under an experimental coarctation of the aorta. Arkh Anat Gistol Em- briol. 1984;86:46-55.
  23. Belenje A, Agarwal K. Bilateral central retinal vein occlusion in a neonate secondary to atrial septal defect and patent ductus arteriosus. Case Rep 2022;15:e247618.
  24. Li C, Zhong P, Yuan H, et al. Retinal microvasculature impairment in patients with congenital heart disease investigated by optical coherence tomography angiography. Clin Experiment Ophthalmol. 2020;48:1219–1228.
  25. Poon, A. W. H., Ma, E. X. H., Vadivel, A., Jung, S., Khoja, Z., Stephens, L., Theébaud, B., & Wintermark, P. (2016). Impact of bronchopulmonary dysplasia on brain and retina. Biology Open, 5(4), 475–483.
  26. Lavric, A., Markelj, S., Ding, J., Mahajan, S., Agrawal, R., & Tekavcic Pompe, M. (2022). Perinatal risk factors associated with central retinal changes in former preterm children on optical coherence tomography angiography. Acta Ophthalmologica, 100(1), e122–e127.
  27. Petersen RA, Rosenthal A. Retinopathy and papilledema in cyanotic heart disease. Pediatrics 1972; 49: 243–249.
  28. Crowe RJ, Kohner EM, Owen SJ, Robinson DM. The retinal vessels in congenital heart disease. Med Biol 1969; 19: 95–99.
  29. Kohner EM, Allen EM, Saunders KB, Emery VM, Pallis C. Electroencephalogram and retinal vessels in congenital cyanotic heart disease before and after surgery. Br Med J 1967; 4: 207–210.
  30. Li C, Zhong P, Yuan H, Dong X, Peng Q, Huang M, Wu Q, Liu B, Xu M, Kuang Y, Zeng X, Xiao Y, Fang Y, Yu H, Yang X. Retinal microvasculature impairment in patients with congenital heart disease investigated by optical coherence tomography angiography. Clin Exp Ophthalmol. 2020 Dec;48(9):1219-1228.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.